Published Online: Monday, November 1, 2004

The article on Home Diagnostic Kits in the September 2004 issue of Pharmacy Times should have said that the FDA has cleared home testing kits for consumer use.

The article on Fluoroquinolones in the September issue should have referred to nalidixic acid as a quinolone.

An error in editing resulted in misinformation in the article, Statins and Diabetes (October 2004). The table should have said that there are currently 6 statins on the market. Ezetimibe (Zetia) and the combination product ezetimibe/simvastatin (Vytorin) should not have been included.

Latest Articles
As today is World AIDS Day, pharmacists across the globe may be renewing their interest in quashing HIV infection and providing support for infected patients.
Pharmacists are in a great position to impart valuable heart-related wisdom to their patients.
Shifts in sleep schedules may increase an individual’s risk for diabetes.
Qualgen has taken corrective actions concerning its compounding facility conditions and sterility processes.
Latest Issues